Yahoo Web Search

Sign In

Search results

  1. www.genmab.comHome | Genmab

    Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases.

    • Pipeline

      Genmab's antibody-based therapeutics have the potential to...

    • Medicines

      Medicines - Home | Genmab

    • Investors

      Genmab is an international biotechnology company that...

    • News Alerts

      The Investor Relations website contains information about...

    • Antibody Technology Platforms

      DuoHexaBody ® combines the dual targeting of Genmab’s...

    • About

      Discover Genmab, an international biotechnology company that...

  2. www.genmab.com › aboutAbout | Genmab

    Discover Genmab, an international biotechnology company that creates,develops and commercializes and commercializes antibody therapeutics to treat cancer and other serious diseases.

  3. en.wikipedia.org › wiki › GenmabGenmab - Wikipedia

    Genmab was founded as a European spin-off of American Biotech company Medarex in February 1999. Danish investment firm BankInvest, under Florian Schönharting, provided the seed investment for the company to start up in Copenhagen. Like Medarex, Genmab began work producing monoclonal antibodies for life-threatening or debilitating ...

  4. www.genmab.com › antibody-science › pipelinePipeline | Genmab

    May 29, 2024 · Genmab's antibody-based therapeutics have the potential to transform the treatment of cancer and other serious diseases. Explore our investigational medicines pipeline.

  5. Images

    • Genmab – Logos Download
    • Genmab (GMAB) Dividends

    View all

  6. www.genmab.com › investor-relationsInvestor Relations | Genmab

    Genmab is an international biotechnology company that develops innovative antibody products, with the vision that our knock-your-socks-off antibody treatments TM transform the treatment of cancer and other serious diseases.

  7. www.genmab.com › antibody-scienceAntibody Science and Innovation - Genmab

    Genmab is using artificial intelligence (A.I.) and machine learning to turbocharge innovation and transform how it researches, develops novel antibody therapies with the goal to make an impact on the lives of patients.

  8. ir.genmab.com › news-releases › news-release-detailsGenmab Completes Acquisition of ProfoundBio - Genmab A/S

    May 21, 2024 · Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash. Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate technology platforms.